Application Note: WB: 1:500-1:1000. ICC/IF: 1:50-1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 43
Form: Liquid
Buffer (with preservative): PBS pH 7.3, 50% glycerol, 0.01% thimerosal.
Concentration: Batch dependent (Please refer to the vial label for the specific concentration.)
Background: This gene encodes the cytosolic form of the enzyme branched-chain amino acid transaminase. This enzyme catalyzes the reversible transamination of branched-chain alpha-keto acids to branched-chain L-amino acids essential for cell growth. Two different clinical disorders have been attributed to a defect of branched-chain amino acid transamination: hypervalinemia and hyperleucine-isoleucinemia. As there is also a gene encoding a mitochondrial form of this enzyme, mutations in either gene may contribute to these disorders. Alternatively spliced transcript variants have been described. [provided by RefSeq, May 2010]
Uniprot ID: P54687
Antigen Species: Human
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 20-190 of human BCAT1 (NP_005495.2).
Purification: Purified by affinity chromatography
Conjugation: Unconjugated
Full Name: branched chain amino acid transaminase 1
English
Deutsch
